Valeant Eyeing Dermatology, Dentistry for M&A: CEO

March 19 (Bloomberg) -- Mike Pearson, chief executive officer of Valeant Pharmaceuticals International Inc., talks about the company's acquisition and growth strategy. He speaks with Stephanie Ruhle and Matt Miller on Bloomberg Television's "Market Makers." (Source: Bloomberg)
Steve Bannon: Vast, Right-Wing Conspirator
16:14 - Behind the scenes of the making of this week's magazine cover with Editor-In-Chief Ellen Pollock and Creative Director Robert Vargas.
  • Deep Dive: Stock Market Pressure Easing, Netflix's Move
  • Are Negative Interest Rates Realistic?
  • Why Bill Gross Is Suing Pimco Over His Ouster